Which medication is most likely responsible for the acute overnight decline in mental status with disorientation and confusion in a 70‑year‑old male taking benzonatate, brompheniramine/dextromethorphan/pseudoephedrine, and acetaminophen/guaifenesin, who has a post‑void residual urine volume of 800 mL?

Brompheniramine is the most likely culprit for this patient's acute delirium

The brompheniramine component of the brompheniramine/dextromethorphan/pseudoephedrine combination is the most responsible agent for this 70-year-old male's overnight mental status decline, particularly given his significant urinary retention (800 mL post-void residual). This first-generation antihistamine has potent anticholinergic properties that are especially problematic in elderly patients and those with urinary retention 1.

Why Brompheniramine is the Primary Offender

Anticholinergic Burden in the Elderly

Brompheniramine is a first-generation H1 antihistamine with strong anticholinergic effects that directly impair cholinergic neurotransmission—a key mechanism in delirium pathogenesis 2, 3. First-generation antihistamines like brompheniramine are more likely to cause dizziness, sedation, and cognitive decline in elderly patients 1. The evidence is clear that anticholinergic medications with these properties are associated with cognitive decline, particularly in elderly populations 2, 3.

Research demonstrates that anticholinergic drugs are important causes of both acute and chronic confusional states, with the total anticholinergic burden determining delirium development rather than any single agent 4. Brompheniramine specifically demonstrates measurable anticholinergic activity at therapeutic doses 5.

The Urinary Retention Connection

The 800 mL post-void residual is a critical clinical finding that points directly to anticholinergic toxicity. Urinary retention is both a risk factor for delirium AND a direct consequence of anticholinergic medication use 6. The FDA label explicitly warns that brompheniramine should be used with caution in patients with urinary bladder neck obstruction 1. This creates a vicious cycle: the anticholinergic drug causes urinary retention, which itself predisposes to delirium, while simultaneously the anticholinergic effects directly impair cognition.

Why Other Medications Are Less Likely

Benzonatate

While benzonatate can cause CNS effects including mental confusion and sedation 7, these are typically isolated instances and less commonly associated with acute delirium compared to anticholinergics. The FDA label lists mental confusion as a potential adverse reaction but does not emphasize elderly vulnerability 7.

Dextromethorphan

Dextromethorphan can induce psychotic symptoms, but this typically occurs with abuse or overmedication at supratherapeutic doses 8, 9. At standard therapeutic doses in this combination product, it's less likely to be the primary cause, though it may contribute to the overall picture.

Pseudoephedrine

Pseudoephedrine can cause agitation and CNS stimulation 8, 10, but the clinical picture here is confusion and disorientation rather than hyperactive agitation. While it may contribute, it's not the primary driver of this presentation.

Acetaminophen/Guaifenesin

These agents have minimal to no CNS effects at therapeutic doses. Guaifenesin lacks significant evidence for efficacy or adverse CNS effects 11, and acetaminophen is not associated with delirium.

Clinical Approach

Immediate Management

1. Discontinue the brompheniramine/dextromethorphan/pseudoephedrine combination immediately 12
2. Address the urinary retention (likely requiring catheterization given the 800 mL residual)
3. Assess for other contributing factors: infection (especially UTI given the retention), dehydration, electrolyte disturbances 12, 13
4. Use validated tools like the Confusion Assessment Method (CAM) to confirm delirium 12, 14, 12

Important Caveats

• Do not assume bacteriuria from the urinary retention is causing the delirium—in elderly patients with delirium and asymptomatic bacteriuria, antibiotics worsen outcomes and increase C. difficile risk 13. Only treat if there are systemic signs of infection (fever, hemodynamic instability) beyond the mental status change.
• The delirium may take days to fully resolve even after stopping the offending agent, as anticholinergic effects can persist 4
• Avoid adding benzodiazepines or other sedating medications, as these will worsen delirium 6, 15

Prevention Going Forward

This patient should never receive first-generation antihistamines again 3, 15. If antihistamine therapy is needed, second-generation agents (cetirizine, fexofenadine) have minimal anticholinergic effects and are safer in the elderly 2. The combination of advanced age, urinary retention, and anticholinergic medication created the perfect storm for delirium in this vulnerable patient 6.